## Abstract ## Background: Several clinical trials have proved that concurrent chemoradiotherapy is more efficacious than radiotherapy alone among high‐risk patients with head and neck squamous cell carcinoma (HNSCC) who undergo surgery. A risk‐group classification defined according to a recursive
Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy
✍ Scribed by Johannes A. Langendijk; Ben J. Slotman; Isaac van der Waal; P. Doornaert; Johannes Berkof; Charles R. Leemans
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 135 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background The current study aimed to evaluate the significance of the cell‐cycle‐control proteins cyclin D1 and p16 as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with docetaxel and radiotherapy. ## Methods Cyclin D1 and/or p16 protein exp
## Abstract ## Background. Our aim was to correlate patterns of failure with target volume delineations in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity‐modulated radiation therapy (IMRT) and to report subjective xerostomia outcomes after IMRT as compared with
## Background: The aim was to evaluate the relationship between nutrition support (ns) on host toxicity and cancer outcome in patients with locally advanced head and neck squamous cell carcinoma (hnscc) undergoing definitive radiotherapy (xrt). ## Methods: We performed a secondary analysis of rad
## Abstract The purpose of our study was to test the predictive value of cisplatin‐DNA adduct levels in head and neck squamous cell carcinoma (HNSCC) patients treated with cisplatin‐radiation. Patients with advanced‐stage HNSCC were treated within a randomized trial, investigating the optimal route